Analytical Data
-
Gene name
SSTR3
- Application
-
Alternative Names
SS-3-R;SS3-R;SS3R;SST3;SSR-28
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P32745
-
Expression Region
1-418 aa
-
AA Sequence
MDMLHPSSVSTTSEPENASSAWPPDATLGNVSAGPSPAGLAVSGVLIPLVYLVVCVVGLLGNSLVIYVVLRHTASPSVTNVYILNLALADELFMLGLPFLAAQNALSYWPFGSLMCRLVMAVDGINQFTSIFCLTVMSVDRYLAVVHPTRSARWRTAPVARTVSAAVWVASAVVVLPVVVFSGVPRGMSTCHMQWPEPAAAWRAGFIIYTAALGFFGPLLVICLCYLLIVVKVRSAGRRVWAPSCQRRRRSERRVTRMVVAVVALFVLCWMPFYVLNIVNVVCPLPEEPAFFGLYFLVVALPYANSCANPILYGFLSYRFKQGFRRVLLRPSRRVRSQEPTVGPPEKTEEEDEEEEDGEESREGGKGKEMNGRVSQITQPGTSGQERPPSRVASKEQQLLPQEASTGEKSSTMRISYL
-
Molecular Weight
47.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SSTR3, or somatostatin receptor type 3, is a member of the G-protein coupled receptor (GPCR) family that plays a critical role in various physiological processes, including regulation of hormone secretion, cell proliferation, and neurotransmission. Dysregulation of SSTR3 has been implicated in several pathological conditions, including neuroendocrine tumors and neurological disorders. The study of SSTR3 recombinant protein is significant for the development of targeted therapies, particularly in cancer treatment, where somatostatin analogs can inhibit tumor growth and hormone-related symptoms. Furthermore, understanding the structure and function of SSTR3 at a molecular level provides insights into GPCR signaling pathways and their implications in human health. Advances in recombinant protein technology have facilitated the production and characterization of SSTR3, enabling researchers to investigate its binding mechanisms, intracellular signaling pathways, and potential as a drug target. This research is crucial for the rational design of novel therapeutics aimed at modulating SSTR3 activity, thereby offering new avenues for treatment strategies in conditions associated with somatostatin receptor dysfunction.
